Skip to main content
. Author manuscript; available in PMC: 2024 Jun 6.
Published in final edited form as: Nat Biomed Eng. 2022 May 9;6(7):819–829. doi: 10.1038/s41551-022-00888-0

Extended Data Fig. 1. Antitumor efficacy of masked IL-12 is linker-dependent.

Extended Data Fig. 1

Mice were treated as described in Fig. 2a. Individual tumor growth curves (a) and survival (b) are shown. Statistical analysis in b was performed using log-rank (Mantel-Cox) test.